THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 85 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is 5.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,000 | -22.2% | 16,898 | +28.8% | 0.00% | – |
| Q3 2016 | $9,000 | +28.6% | 13,118 | +12.0% | 0.00% | – |
| Q2 2016 | $7,000 | -99.1% | 11,711 | -99.3% | 0.00% | – |
| Q1 2016 | $741,000 | -9.3% | 1,610,250 | -5.4% | 0.00% | – |
| Q4 2015 | $817,000 | -87.9% | 1,701,716 | +2.8% | 0.00% | -100.0% |
| Q3 2015 | $6,735,000 | +1.1% | 1,654,700 | +0.4% | 0.00% | 0.0% |
| Q2 2015 | $6,662,000 | +0.6% | 1,648,904 | +1.1% | 0.00% | 0.0% |
| Q1 2015 | $6,624,000 | +41.3% | 1,631,517 | +10.6% | 0.00% | +100.0% |
| Q4 2014 | $4,689,000 | +2.3% | 1,474,656 | +16.2% | 0.00% | 0.0% |
| Q3 2014 | $4,582,000 | -6.0% | 1,269,168 | +3.1% | 0.00% | 0.0% |
| Q2 2014 | $4,875,000 | -22.8% | 1,231,132 | -7.2% | 0.00% | -50.0% |
| Q1 2014 | $6,317,000 | +5.0% | 1,327,154 | +3.0% | 0.00% | 0.0% |
| Q4 2013 | $6,019,000 | -3.9% | 1,288,763 | -4.3% | 0.00% | 0.0% |
| Q3 2013 | $6,264,000 | +0.3% | 1,347,187 | +13.4% | 0.00% | 0.0% |
| Q2 2013 | $6,248,000 | – | 1,187,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 555,965 | $2,007,000 | 2.02% |
| FORTALEZA ASSET MANAGEMENT INC/ | 96,925 | $350,000 | 0.16% |
| Rhenman & Partners Asset Management AB | 121,537 | $439,000 | 0.13% |
| Baker Brothers Advisors | 2,158,141 | $7,791,000 | 0.10% |
| Perceptive Advisors | 160,000 | $578,000 | 0.06% |
| FEDERATED HERMES, INC. | 4,391,838 | $15,855,000 | 0.05% |
| Spark Investment Management LLC | 61,100 | $219,000 | 0.03% |
| SMITH ASSET MANAGEMENT GROUP LP | 190,378 | $687,000 | 0.02% |
| Princeton Alpha Management LP | 28,329 | $102,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 31,000 | $112,000 | 0.02% |